Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?

Widely access to interferon-free direct-acting antiviral regimens (IFN-free DAA) is poised to dramatically change the impact of the HCV epidemic among people who inject drugs (PWID). We evaluated the long-term effect of increasing HCV testing, treatment and engagement into harm-reduction activities,...

Full description

Bibliographic Details
Main Authors: Viviane D Lima, Ignacio Rozada, Jason Grebely, Mark Hull, Lillian Lourenco, Bohdan Nosyk, Mel Krajden, Eric Yoshida, Evan Wood, Julio S G Montaner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4669174?pdf=render